Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Btissam Chami"'
Autor:
Maria Sebti, Camille Petit-Hoang, Btissam Chami, Étienne Audureau, Catherine Cordonnier-Jourdin, Muriel Paul, Franck Pourcine, Philippe Grimbert, Clément Ourghanlian, Marie Matignon
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionIn sensitized deceased donor kidney allograft recipients, the most frequent induction therapy is anti-thymocyte globulins (ATG), including Thymoglobulin® (Thymo) and ATG-Fresenius (ATG-F).MethodsWe conducted a 3-year monocentric observat
Externí odkaz:
https://doaj.org/article/755cf34d9d7d4fe5bb15487d00188232
Autor:
Btissam Chami, Makoto Okuda, Morvarid Moayeri, France Pirenne, Yoko Hidaka, Ashok Nambiar, Zhili Song, Olivier Bedel, Bailin Zhang, Joern Hopke, Gejing Deng, Chen Zhu, Sandrine Macé, Marielle Chiron, Francisco Adrian, Taro Fukao, Frank G. Basile, Thomas Martin
Publikováno v:
Transfusion. 62:2334-2348
There are two FDA-approved anti-CD38 monoclonal antibodies for treatment of multiple myeloma: isatuximab and daratumumab. Owing to expression of CD38 on reagent red blood cells (RBCs), these antibodies interfere with indirect antiglobulin tests (IATs
Insights intoanti‐D formation in carriers ofRhD variants through studies of3D intraprotein interactions
Autor:
Aline Floch, France Pirenne, Aurélie Barrault, Btissam Chami, Cécile Toly‐Ndour, Christophe Tournamille, Alexandre G. Brevern
Publikováno v:
Transfusion
Transfusion, Wiley, 2021, 61 (4), pp.1286-1301. ⟨10.1111/trf.16301⟩
Transfusion, Wiley, 2021, 61 (4), pp.1286-1301. ⟨10.1111/trf.16301⟩
International audience; Background: Many RhD variants associated with anti-D formation (partial D) in carriers exposed to the conventional D antigen carry mutations affecting extracellular loop residues. Surprisingly, some carry mutations affecting t
Autor:
Jocelyn Roze, Elodie Maenulein, Isabelle Vinatier, Sadaf Pakdaman, Anoosha Habibi, Btissam Chami, Christophe Tournamille, France Pirenne, Aline Floch
Publikováno v:
Transfusion Clinique et Biologique. 28:S48-S49
Deux observations de transmission apparemment non mendélienne du phénotype RH : apport du génotypage
Autor:
Isabelle Vinatier, Noémie Barvaux, Elvira Deprey, Mireille Deschang, Btissam Chami, France Pirenne, Christophe Tournamille, Aline Floch
Publikováno v:
Transfusion Clinique et Biologique. 28:S71-S72
Publikováno v:
Transfusion Medicine and Hemotherapy. 45:264-270
This review presents the French strategy for blood group genotyping in high-responder and newly diagnosed sickle cell disease (SCD) patients. In addition to FY, JK, and MNS genotyping, the RH blood group system is now explored in SCD patients in Fran
Autor:
Aline Floch, Isabelle Vinatier, Btissam Chami, Mélanie Gentil, Christophe Tournamille, France Pirenne
Publikováno v:
Transfusion Clinique et Biologique. 28:S74
Publikováno v:
Transfusion Clinique et Biologique. 28:S40
Autor:
Zhili Song, Olivier Bedel, Bailin Zhang, Joern Hopke, Gejing Deng, Sandrine Macé, Marielle Chiron, Francisco Adrian, Taro Fukao, Frank Basile, France Pirenne, Makoto Okuda, Morvarid Moayeri, Btissam Chami, Yoko Hidaka, Ashok Nambiar, Thomas Martin, Chen Zhu
Publikováno v:
Cancer Research. 81:1888-1888
Introduction: Two anti-CD38 monoclonal antibodies (mAb) are approved for the treatment of multiple myeloma: isatuximab (Isa) and daratumumab (Dara); binding to CD38 on red blood cells (RBCs) results in false positive agglutination on indirect antiglo
Autor:
Anoosha Habibi, Armand Mekontso-Dessap, Constance Guillaud, Marc Michel, Keyvan Razazi, Mehdi Khellaf, Btissam Chami, Dora Bachir, Claire Rieux, Giovanna Melica, Bertrand Godeau, Frédéric Galacteros, Pablo Bartolucci, France Pirenne
Publikováno v:
American Journal of Hematology. 91:989-994
Delayed hemolytic transfusion reaction (DHTR) is one of the most feared complications of sickle-cell disease (SCD). We retrospectively analyzed the clinical and biological features, treatments and outcomes of 99 DHTRs occurring in 69 referral center